[Combined treatment of palmoplantar syndrome in patients under antitumor therapy]

Autor: L S, Kruglova, E A, Shatokhina, M A, Elfimov, V E, Illarionov, A V, Chervinskaya, V V, Portnov, E V, Filatova, M S, Petrova
Rok vydání: 2016
Předmět:
Zdroj: Meditsina truda i promyshlennaia ekologiia. (2)
ISSN: 1026-9428
Popis: Observation covered 12 patients under various antitumor medications. Group 1 was formed of patients with developed palmoplantar syndrome varying in severity, who received complex treatment including IR-therapy and local antioxidant medication. Group 2 included patients without palmoplantar syndrome, who received preventive treatment with IR-therapy. All patients of group 1 demonstrated lower severity of palmoplantar syndrome manifestations. In group 2, 80% of the patients avoided palmoplantar syndrome development, and 20% of the patients had light course of the syndrome manifestations. Patients at high risk of palmoplantar syndrome under antitumor therapy are recommended to undergo IR-therapy and local antioxidant medication.
Databáze: OpenAIRE